Search research articles
Contact Us
Filters
Showing results (131-140 of 485) with videos related to
Page
of 49
Sort By:
Medical Mycology
|
January 19, 2002
Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia
E Brummer, A Maqbool, D A Stevens
Journal of Leukocyte Biology
|
December 12, 2001
In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages
E Brummer, A Maqbool, D A Stevens
Antimicrobial Agents and Chemotherapy
|
September 1, 1994
Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing
E Brummer, F Nassar, D A Stevens
Reviews of Infectious Diseases
|
January 1, 1987
Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole
A Ganer, E Arathoon, D A Stevens
The Journal of Infectious Diseases
|
October 1, 1996
Role of extended culture time on synergy of fluconazole and human monocyte-derived macrophages in clearing Candida albicans
S Gujral, E Brummer, D A Stevens
Clinical and Experimental Immunology
|
September 1, 2001
Effects of granulocyte-macrophage colony stimulating factor (GM-CSF) in vivo on cytokine production and proliferation by spleen cells
S Khatami, E Brummer, D A Stevens
Cellular Immunology
|
August 1, 1995
Macrophage colony-stimulating factor (M-CSF) induction of enhanced anticryptococcal activity in human monocyte-derived macrophages: synergy with fluconazole for killing
F Nassar, E Brummer, D A Stevens
Antimicrobial Agents and Chemotherapy
|
November 1, 1995
Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity
F Nassar, E Brummer, D A Stevens
Antimicrobial Agents and Chemotherapy
|
September 1, 1994
Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans
F Nassar, E Brummer, D A Stevens
Infection Control and Hospital Epidemiology
|
December 1, 1994
Postexposure varicella management: further comments
D Haiduven, D A Stevens, C Hench
Page
of 49
Search research articles
Search
Showing results (131-140 of 485) with videos related to
Sort By:
Page
of 49
Medical Mycology
|
January 19, 2002
Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia
E Brummer, A Maqbool, D A Stevens
Journal of Leukocyte Biology
|
December 12, 2001
In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages
E Brummer, A Maqbool, D A Stevens
Antimicrobial Agents and Chemotherapy
|
September 1, 1994
Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing
E Brummer, F Nassar, D A Stevens
Reviews of Infectious Diseases
|
January 1, 1987
Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole
A Ganer, E Arathoon, D A Stevens
The Journal of Infectious Diseases
|
October 1, 1996
Role of extended culture time on synergy of fluconazole and human monocyte-derived macrophages in clearing Candida albicans
S Gujral, E Brummer, D A Stevens
Clinical and Experimental Immunology
|
September 1, 2001
Effects of granulocyte-macrophage colony stimulating factor (GM-CSF) in vivo on cytokine production and proliferation by spleen cells
S Khatami, E Brummer, D A Stevens
Cellular Immunology
|
August 1, 1995
Macrophage colony-stimulating factor (M-CSF) induction of enhanced anticryptococcal activity in human monocyte-derived macrophages: synergy with fluconazole for killing
F Nassar, E Brummer, D A Stevens
Antimicrobial Agents and Chemotherapy
|
November 1, 1995
Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity
F Nassar, E Brummer, D A Stevens
Antimicrobial Agents and Chemotherapy
|
September 1, 1994
Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans
F Nassar, E Brummer, D A Stevens
Infection Control and Hospital Epidemiology
|
December 1, 1994
Postexposure varicella management: further comments
D Haiduven, D A Stevens, C Hench
Page
of 49